Apyx Medical Corporation (FRA:BOV)

Apyx Medical Statistics

Total Valuation

Apyx Medical has a market cap or net worth of EUR 141.79 million. The enterprise value is 154.10 million.

Market Cap	141.79M
Enterprise Value	154.10M

Important Dates

The next estimated earnings date is Friday, March 13, 2026.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.00M
Shares Outstanding	n/a
Shares Change (YoY)	+15.78%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	13.42%
Owned by Institutions (%)	22.32%
Float	28.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.47
PB Ratio	27.36
P/TBV Ratio	28.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.44
EV / Sales	3.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.05

Financial Position

The company has a current ratio of 4.44, with a Debt / Equity ratio of 6.45.

Current Ratio	4.44
Quick Ratio	3.47
Debt / Equity	6.45
Debt / EBITDA	n/a
Debt / FCF	-4.13
Interest Coverage	-1.63

Financial Efficiency

Return on equity (ROE) is -168.13% and return on invested capital (ROIC) is -12.46%.

Return on Equity (ROE)	-168.13%
Return on Assets (ROA)	-10.06%
Return on Invested Capital (ROIC)	-12.46%
Return on Capital Employed (ROCE)	-20.49%
Revenue Per Employee	185,577
Profits Per Employee	-56,329
Employee Count	220
Asset Turnover	0.81
Inventory Turnover	1.97

Taxes

In the past 12 months, Apyx Medical has paid 225,860 in taxes.

Income Tax	225,860
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +120.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+120.78%
50-Day Moving Average	2.66
200-Day Moving Average	1.71
Relative Strength Index (RSI)	59.30
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.32

Income Statement

In the last 12 months, Apyx Medical had revenue of EUR 40.83 million and -12.39 million in losses. Loss per share was -0.31.

Revenue	40.83M
Gross Profit	25.58M
Operating Income	-8.10M
Pretax Income	-12.15M
Net Income	-12.39M
EBITDA	-7.61M
EBIT	-8.10M
Loss Per Share	-0.31

Balance Sheet

The company has 21.42 million in cash and 33.42 million in debt, giving a net cash position of -12.00 million.

Cash & Cash Equivalents	21.42M
Total Debt	33.42M
Net Cash	-12.00M
Net Cash Per Share	n/a
Equity (Book Value)	5.18M
Book Value Per Share	0.13
Working Capital	32.23M

Cash Flow

In the last 12 months, operating cash flow was -7.17 million and capital expenditures -923,893, giving a free cash flow of -8.09 million.

Operating Cash Flow	-7.17M
Capital Expenditures	-923,893
Free Cash Flow	-8.09M
FCF Per Share	n/a

Margins

Gross margin is 62.65%, with operating and profit margins of -19.84% and -30.35%.

Gross Margin	62.65%
Operating Margin	-19.84%
Pretax Margin	-29.77%
Profit Margin	-30.35%
EBITDA Margin	-18.64%
EBIT Margin	-19.84%
FCF Margin	n/a

Dividends & Yields

Apyx Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.78%
Shareholder Yield	-15.78%
Earnings Yield	-8.74%
FCF Yield	-5.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Apyx Medical has an Altman Z-Score of -0.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.37
Piotroski F-Score	3